logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
J

Jeffrey I. Weitz

Hamilton Health Sciences

118H-index
774Paper Count
7.4WCitation Count
Published Papers 374
Publication Date
logo
Histidine-rich Glycoprotein Modulates Platelet Adhesion and Aggregation by Binding to GPIbα and GPIIb/IIIa
errBlood
IF23.1
err2026-06-05
err0
PREAI
errRida A. Malik; Ji Zhou; Miguel A. D. Neves; Rex Huang; Xinyi Guo; Rawaa H. Hussain; James C. Fredenburgh; Peter L. Gross; Heyu Ni; Colin A. Kretz; Jeffrey I. Weitz
errShare
errSave
Canagliflozin Is a Novel Androgen Receptor Pathway Inhibitor for Castrate-Sensitive and Castrate-Resistant Prostate Cancer
errCancer Letters
IF10.1
err2026-04-24
err0
PREAI
errAmr Ali; Fiorella Di Pastena; Olga-Demetra Biziotis; Simon Wang; Evangelia E. Tsakiridis; Daniel Del Rosso; James C. Fredenburgh; Jeffrey I. Weitz; Sebastien J. Hotte; Jonathan L. Bramson; Gregory R. Steinberg; Theodoros Tsakiridis
errShare
errSave
Antibody BAY3018250 against antiplasmin enhances plasminogen activation in vitro and thrombolysis in rabbits
errJournal of Thrombosis and Haemostasis
IF5
err2026-03-04
err0
errOAAI
errC.J. Lindo; Peng Liao; Alina Khan; Daivat Bhavsar; Priyanka Srivastava; Julia Glunz; James C. Fredenburgh; Andreas Wilmen; Stefan Heitmeier; Jeffrey I. Weitz
errShare
errSave
The win ratio for evaluating edoxaban versus dalteparin for cancer-associated venous thromboembolism: an analysis of the randomized Hokusai VTE cancer trial
errJournal of Thrombosis and Haemostasis
IF5
err2025-12-19
err0
errOAAI
errNick van Es; Luuk J.J. Scheres; Kristen M. Sanfilippo; Harry Büller; Marc Carrier; Marcello Di Nisio; Michael Grosso; Renato D. Lopes; William F. McIntyre; Bjorn Redfors; Annelise Segers; Peter Verhamme; Jeffrey I. Weitz; Patrick M. Bossuyt; Deborah M. Siegal
errShare
errSave
Efficacy and safety of REGN9933A2 and REGN7508Cat for preventing postoperative venous thromboembolism (ROXI-VTE-I and ROXI-VTE-II): two randomised, open-label, phase 2 trials
errThe Lancet
IF97.3
err2025-11-08
err0
PREAI
errJeffrey I Weitz; Aaron P Kithcart; Meagan P O'Brien; Oren Levy; Ethan Marin; Margaret Onisko; Kusha A Mohammadi; Dateng Li; Karoline A Meagher; Hannah H Chang; Benjamin A Olenchock; David E Gutstein; Annelise Segers; Robin S Roberts; Marc P Bonaca; Gary E Raskob
errShare
errSave
Self-Cleaning Menstrual Cups with Plant-Based Biodegradable Superabsorbent Fibrous Tablets for Hygienic and Sustainable Period Care
errACS Applied Materials & Interfaces
IF8.2
err2025-10-10
err0
PREAI
errShaghayegh Moghimikandelousi; Fereshteh Bayat; Lubna Najm; Rida A. Malik; Aishwarya Bhavan; Farbod Azaripour Masooleh; Leisa Hirtz; Jeffrey I. Weitz; Zeinab Hosseinidoust; Tohid F. Didar
errShare
errSave
Sex differences in venous thromboembolism outcomes: findings from the GARFIELD-VTE registry
errEuropean Journal of Internal Medicine
IF6.1
err2025-08-25
err0
errOAAI
errPaolo Prandoni; Meg Fluharty; Sebastian Schellong; Henri Bounameaux; Sylvia Haas; Lorenzo G Mantovani; Sherif Sholkamy; Katsuhiro Kondo; Harry Gibbs; Zhi-Cheng Jing; Chern-En Chiang; Peter Verhamme; Alexander GG Turpie; Jeffrey I. Weitz; Walter Ageno; Shinya Goto; Pantep Angchaisuksiri; Karen Pieper; Ajay K Kakkar
errShare
errSave
Biologically Active Implants Prevent Mortality in a Mouse Sepsis Model
errAdvanced Healthcare Materials
IF9.6
err2025-08-15
err0
errOAAI
errMartin Stark; Fereshteh Bayat; Sara Rahmani; Mathura Thirugnanasampanthar; Taylor Kramer; Elise Schwarz; David Wilson; Jeffrey I. Weitz; Zeinab Hosseinidoust; Tohid F. Didar
errShare
errSave
EFFECTS OF MILVEXIAN ALONE OR WITH HEPARIN ON CATHETER-INDUCED CLOTTING AND THROMBIN GENERATION
errJournal of Thrombosis and Haemostasis
IF5
err2025-07-11
err0
PREAI
errRuiqi Yin; James C. Fredenburgh; Jeffrey I. Weitz
errShare
errSave
DOAC–Stop reverses the anticoagulant effect of asundexian and milvexian
errJournal of Thrombosis and Haemostasis
IF5
err2025-06-06
err0
PREAI
errElla K. Fitzpatrick; James C. Fredenburgh; Jeffrey I. Weitz
errShare
errSave
Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH: reply
errJOURNAL OF THROMBOSIS AND HAEMOSTASIS
IF5
err2025-05-01
err0
PREAI
errLevy, Jerrold H.; Shaw, Joseph R.; Connors, Jean M.; Douketis, James; Weitz, Jeffrey I.
errShare
errSave
Treatment and outcomes after on-treatment recurrent venous thromboembolism in patients with cancer: a post hoc analysis of the Hokusai venous thromboembolism cancer study
errJournal of Thrombosis and Haemostasis
IF5
err2025-03-04
err0
errOAAI
errVincent R. Lanting; Kika van Bergen en Henegouwen; Floris T.M. Bosch; Michael A. Grosso; Annelise Segers; Gary E. Raskob; T. Pieter Willem Kamphuisen; Harry R. Büller; Peter Verhamme; Jeffrey I. Weitz; Marcello Di Nisio; Marc Carrier; Nick van Es; Tzu-Fei Wang
errShare
errSave
Oral factor xia inhibitor milvexian after a recent acute coronary syndrome: Rationale and design of the phase 3 (Librexia ACS)
errAMERICAN HEART JOURNAL
IF3.5
err2025-02-01
err0
errOAAI
errGibson, C. Michael; Bahit, M. Cecilia; Mehran, Roxana; Mehta, Shamir R.; Al Lamee, Rasha; Goto, Shinya; Weitz, Jeffrey I.; Horrow, Jay; Barnathan, Elliot S.; Harrington, Robert A.; Mahaffey, Kenneth W.; Lam, Carolyn S. P.; Pieper, Karen S.; Johnston, S. Claiborne; Hankey, Graeme J.; Plotnikov, Alexei N.; Li, Danshi; Deng, Hsiaowei; Steg, Philippe Gabriel
errShare
errSave
Exosite crosstalk in thrombin
errJOURNAL OF THROMBOSIS AND HAEMOSTASIS
IF5
err2025-01-01
err0
PREAI
errFredenburgh, James C.; Weitz, Jeffrey I.
errShare
errSave
XI before X: The Promise of Factor XI Inhibitors
errKIDNEY INTERNATIONAL REPORTS
IF5.7
err2025-01-01
err0
errOAAI
errWeitz, Jeffrey I.; Alzayer, Husam
errShare
errSave
A Phase 1, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered SRSD107 in Healthy Subjects
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errYue, Patrick; Qu, Emma; Pan, Jie; Weitz, Jeffrey; Ji, Qunsheng
errShare
errSave
Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design
errAMERICAN HEART JOURNAL
IF3.5
err2024-11-01
err5
errOAAI
errJain, Sneha S.; Mahaffey, Kenneth W.; Pieper, Karen S.; Shimizu, Wataru; Potpara, Tatjana; Ruff, Christian T.; Kamel, Hooman; Lewis, Basil S.; Cornel, Jan H.; Kowey, Peter R.; Horrow, Jay; Strony, John; Plotnikov, Alexei N.; Li, Danshi; Weng, Stephen; Donahue, Julia; Gibson, C. Michael; Steg, P. Gabriel; Mehran, Roxana; Weitz, Jeffrey I.; Johnston, S. Claiborne; Hankey, Graeme J.; Harrington, Robert A.; Lam, Carolyn S. P.
errShare
errSave
Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH
errJOURNAL OF THROMBOSIS AND HAEMOSTASIS
IF5
err2024-10-01
err6
PREAI
errLevy, Jerrold H.; Shaw, Joseph R.; Castellucci, Lana A.; Connors, Jean M.; Douketis, James; Lindhoff-Last, Edelgard; Rocca, Bianca; Samama, Charles Marc; Siegal, Deborah; Weitz, Jeffrey I.
errShare
errSave
Histidine-Rich Glycoprotein Modulates the Toxic Effects of High-Dose Polyphosphate in Mice
errARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
IF7.4
err2024-07-01
err1
PREAI
errMalik, Rida A.; Zhou, Ji; Fredenburgh, James C.; Crosby, Jeff; Revenko, Alexey S.; Healey, Jeff S.; Weitz, Jeffrey I.
errShare
errSave
Global Health Burden of Venous Thromboembolism
errARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
IF7.4
err2024-05-01
err6
PREAI
errWendelboe, Aaron; Weitz, Jeffrey I.
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
S
Salim Yusuf
H-index: 265 · Papers: 2.2K
H
Harlan M. Krumholz
H-index: 216 · Papers: 2.8K
G
Gregory Y.H. Lip
H-index: 212 · Papers: 5.6K
D
Deepak L. Bhatt
H-index: 197 · Papers: 3.7K
P
Peter Carmeliet
H-index: 192 · Papers: 1.4K
View more